Cargando…
Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts
INTRODUCTION: Buruli ulcer (BU) is an infectious skin disease, caused by Mycobacterium ulcerans, endemic in more than 30 countries worldwide especially Africa. Brong-Ahafo Region implemented WHO recommended daily treatment with streptomycin and rifampicin for eight weeks (SR8). Yet limited assessmen...
Autores principales: | Iddrisah, Florence Nzilanye, Yeboah-Manu, Dorothy, Nortey, Pricillia Awoh, Nyarko, Kofi Mensah, Anim, Jones, Antara, Simon Nyovuura, Kenu, Ernest, Wurapa, Fred, Afari, Edwin Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257010/ https://www.ncbi.nlm.nih.gov/pubmed/28149438 http://dx.doi.org/10.11604/pamj.supp.2016.25.1.6203 |
Ejemplares similares
-
Training Ghanaian frontline healthcare workers in public health surveillance and disease outbreak investigation and response
por: Ameme, Donne Kofi, et al.
Publicado: (2016) -
Secondary Bacterial Infections of Buruli Ulcer Lesions Before and After Chemotherapy with Streptomycin and Rifampicin
por: Yeboah-Manu, Dorothy, et al.
Publicado: (2013) -
Direct observation of outpatient management of malaria in a rural ghanaian district
por: Ameme, Donne Kofi, et al.
Publicado: (2014) -
Meningitis outbreak investigation in Nkoranza South Municipality in Brong Ahafo Region, Ghana, February, 2016
por: Asiedu, Ernest Konadu, et al.
Publicado: (2018) -
Development of Highly Organized Lymphoid Structures in Buruli Ulcer Lesions after Treatment with Rifampicin and Streptomycin
por: Schütte, Daniela, et al.
Publicado: (2007)